PHARMACOKINETICS OF 4'EPI-DOXORUBICIN AFTER INTRAVENOUS AND INTRAVESICAL ADMINISTRATION

被引：0
|
作者：
VANDERVIJGH, WJF
WEENEN, H
OSTEROP, A
VANDERPOORT, SEJM
KURTH, KK
BOGDANOWICZ, JF
PINEDO, HM
机构：
[1] FREE UNIV HOSP AMSTERDAM,DEPT ONCOL,1081 HV AMSTERDAM,NETHERLANDS
[2] ERASMUS UNIV,DEPT UROL,3000 DR ROTTERDAM,NETHERLANDS
来源：
BRITISH JOURNAL OF CANCER | 1985年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：463 / 464
页数：2
相关论文
共 50 条
  • [41] PHASE-II EVALUATION OF 4'EPI-DOXORUBICIN IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA
    FERRAZZI, E
    PAPPAGALLO, GL
    NICOLETTO, O
    FORNASIERO, A
    REFATTI, F
    CARTEI, G
    VINANTE, O
    FIORENTINO, MV
    TUMORI, 1984, 70 (03) : 297 - 300
  • [42] PHASE-II TRIAL OF 4'-EPI-DOXORUBICIN IN PATIENTS WITH ADVANCED MALIGNANT-MELANOMA
    BERMAN, E
    CASPER, ES
    HOWARD, J
    WITTES, RE
    CANCER TREATMENT REPORTS, 1984, 68 (04): : 679 - 680
  • [43] PHASE-II EVALUATION OF 4'-EPI-DOXORUBICIN IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
    MICHAELSON, R
    KEMENY, N
    YOUNG, C
    CANCER TREATMENT REPORTS, 1982, 66 (09): : 1757 - 1758
  • [44] Pharmacokinetics of aminolevulinic acid after intravesical administration to dogs
    Dalton, JT
    Zhou, DS
    Mukherjee, A
    Young, D
    Tolley, EA
    Golub, AL
    Meyer, MC
    PHARMACEUTICAL RESEARCH, 1999, 16 (02) : 288 - 295
  • [45] Pharmacokinetics of Aminolevulinic Acid After Intravesical Administration to Dogs
    James T. Dalton
    Diansong Zhou
    Arnab Mukherjee
    David Young
    Elizabeth A. Tolley
    Allyn L. Golub
    Marvin C. Meyer
    Pharmaceutical Research, 1999, 16 : 288 - 295
  • [46] ERYTHROMYCIN - PHARMACOKINETICS AFTER INTRAVENOUS ADMINISTRATION
    MATHER, LE
    AUSTIN, KL
    PHILPOT, CR
    MCDONALD, PJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1978, 23 (01) : 120 - 121
  • [47] PHASE-II TRIAL OF 4'-EPI-DOXORUBICIN IN ADVANCED-CARCINOMA OF HEAD AND NECK ORIGIN
    MAGEE, MJ
    HOWARD, J
    BOSL, GJ
    WITTES, RE
    CANCER TREATMENT REPORTS, 1985, 69 (01): : 125 - 126
  • [48] Randomized study comparing 4′-epi-doxorubicin (epirubicin) versus doxorubicin as a part of induction treatment in adult acute lymphoblastic leukemia
    Bhutani, M
    Kumar, L
    Vora, A
    Bhardwaj, N
    Pathak, AK
    Singh, R
    Kochupillai, V
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (04) : 241 - 247
  • [49] RANDOMIZED TRIAL COMPARING COMBINATIONS OF CYCLOPHOSPHAMIDE AND CISPLATIN WITHOUT OR WITH DOXORUBICIN OR 4'-EPI-DOXORUBICIN IN THE TREATMENT OF ADVANCED OVARIAN-CANCER
    HERNADI, Z
    JUHASZ, B
    POKA, R
    LAMPE, LG
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1988, 27 (02) : 199 - 204
  • [50] PHASE-II TRIAL OF 4'-EPI-DOXORUBICIN IN LOCALLY ADVANCED OR METASTATIC GASTRIC-CANCER
    CAZAP, E
    ESTEVEZ, R
    BRUNO, M
    LEVY, D
    ALGAMIZ, C
    CHACON, R
    BADANO, C
    ROMERO, A
    DESIMONE, G
    ROCA, E
    ARTEAGA, C
    HANNOIS, A
    KOTLIAR, M
    WOOLEY, P
    TUMORI JOURNAL, 1988, 74 (03): : 313 - 315
12345